Registry to Evaluate Chinese Real-World Clinical Outcomes in Patients With AF Using the WATCHMAN Left Atrial Appendage Closure Technology
NCT ID: NCT03917563
Last Updated: 2019-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1050 participants
INTERVENTIONAL
2019-04-20
2024-04-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
China REgistry of WATCHMAN
NCT03014557
Left Atrial Appendage Occlusion in Patients With Non-valvular Atrial Fibrillation From Shanghai
NCT03987945
Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China
NCT06830499
Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease
NCT07267117
Study on the Significance of Auricular Clip in Prevention and Treatment of Valvular Heart Disease Atrial Thrombosis
NCT05263024
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
WATCHMAN LAA occluder treatment
WATCHMAN LAA occluder
WATCHMAN LAA occluder
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
WATCHMAN LAA occluder
WATCHMAN LAA occluder
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient is eligible for a WATCHMAN device according to current international and local guide-lines and per physician discretion;
3. Patient is willing and capable of providing informed consent to participate in all procedures associated with receiving a WATCHMAN device at an approved clinical investigational center.
Exclusion Criteria
2. Patient is a woman of childbearing potential who is, or plans on becoming, pregnant during the duration of follow-up assessments required as part of the WATCHMAN procedure.
3. Patient is unable or not willing to complete follow-up visits and examination as required as part of the WATCHMAN procedure.
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Tiantan Hospital
OTHER
Beijing Hospital
OTHER_GOV
the PLA General Hospital
UNKNOWN
Beijing Chao Yang Hospital
OTHER
Peking University First Hospital
OTHER
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
OTHER
Shanghai 10th People's Hospital
OTHER
Changhai Hospital
OTHER
Dongfang Hospital Affiliated to Tongji University
OTHER
Shanghai 6th People's Hospital
OTHER
Ruijin Hospital
OTHER
Shanghai Thoracic Hospital
UNKNOWN
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
OTHER
Shenzhen Sun Yat-sen Cardiovascular Hospital
OTHER
Tianjin Medical University General Hospital
OTHER
Southwest Hospital, China
OTHER
Shengjing Hospital
OTHER
The First Affiliated Hospital of Dalian Medical University
OTHER
Central Hospital of Dalian
UNKNOWN
General Hospital of Shenyang Military Region
OTHER
Qilu Hospital of Shandong University
OTHER
The Second Hospital of Hebei Medical University
OTHER
Shanxi Cardiovascular Hospital
OTHER
People's Hospital of Taizhou
UNKNOWN
The First Affiliated Hospital with Nanjing Medical University
OTHER
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Ningbo No. 1 Hospital
OTHER
Sir Run Shaw Hospital
UNKNOWN
First Affiliated Hospital of Wenzhou Medical University
OTHER
Second Affiliated Hospital of Wenzhou Medical University
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Wuhan Asia Heart Hospital
OTHER
First Affiliated Hospital Xi'an Jiaotong University
OTHER
General Hospital of Ningxia Medical University
OTHER
Sichuan Provincial People's Hospital
OTHER
West China Hospital
OTHER
ZhuHai Hospital
OTHER
First Affiliated Hospital of Xinjiang Medical University
OTHER
Xijing Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ling Tao
Role: PRINCIPAL_INVESTIGATOR
Xijing Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ling Tao
Xi’an, Shanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ling Tao, MD, PhD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Gao C, Su F, Liu J, Zhang T, Ning Z, Yang B, Chu H, He B, Zhang J, Zhou L, Li Y, Zhang Y, Hu H, Xu Y, Zeng J, Guo J, Su X, Ruan ZB, Liu H, Wang P, Garg S, Soliman O, Holmes DR Jr, Serruys PW, Tao L; RECORD Investigators. 1-Year Clinical Outcomes and the Impact of Procedural Configurations in Left Atrial Appendage Occlusion Patients. JACC Asia. 2024 Oct 1;4(10):777-790. doi: 10.1016/j.jacasi.2024.07.013. eCollection 2024 Oct.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KY20182078-X-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.